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Abstract 
Fibroblast growth factor 2 (FGF-2) – an important paracrine growth factor – binds electrostatically 
with low micro-molar affinity to heparan sulphates present on extracellular matrix proteins. A 
single molecular analysis served as a basis to decipher the nanomechanical mechanism of the 
interaction between FGF-2 and the heparan sulphate surrogate – heparin – with a modular atomic 
force microscope (AFM) design combining magnetic actuators with force measurements at the 
low force regime (101 – 104 pN/s).  Unbinding events between FGF-2–heparin complexes were 
specific and short-lived.  Binding between FGF-2 and heparin had strong slip bond characteristics 
as demonstrated by a decrease of life-time with tensile force on the complex. Unbinding forces 
between FGF-2 and heparin were further detailed at different pH as relevant for (patho-) 
physiological conditions. An acidic pH environment (5.5) modulated FGF-2 – heparin binding as 
demonstrated by enhanced rupture forces needed to release FGF-2 from heparin-FGF-2 complex 
as compared to physiological conditions. This study provides a mechanistic and hypothesis driven 
model on how molecular forces may impact FGF-2 release and storage during tissue remodeling 
and repair.  
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Introduction 
The extracellular matrix (ECM) is composed of various structural and adhesive biomolecules, 
forming a dense 3 dimensional (3D) network in tissues and organs. Apart from being an anchorage 
scaffold for cells, the ECM plays a pivotal role in spatial and temporal coordination of growth 
factors (GF).1-2 One prominent example is fibroblast growth factor 2 (FGF-2, basic FGF), binding 
electrostatically in the low micro-molar range to negatively charged heparan sulphate (HS) 
polysaccharides 3 4 (Figure 1A). After cellular secretion, FGF-2 is stored in the ECM on HS of 
proteoglycans such perlecan5 and agrin6 as well as on basement membranes of connective tissue.7 
It is for this mechanism that the activity of FGF-2 is linked to ECM remodeling, degradation and 
turnover.8 As potent mitogenic growth factor, FGF-2 is spatially and temporarily tightly regulated 
during embryonal development and in tissue repair9-10, showing proliferative effects on a large 
number of cell types derived from mesodermal and ectodermal origin, including  fibroblasts, 
mesenchymal stem cells and endothelial cells.11  
Cell stimulation requires the formation of a ternary complex composed of FGF-2, FGF-receptor, 
and HS co-receptor located on the cell surface.12 Therefore, the interaction of FGF-2 and heparin 
– a HS surrogate – has been extensively studied based on both energetic (isothermal titration 
calorimetry; ITC)3 and kinetic characterization (surface plasmon resonance; SPR).13 However, 
these methods do not allow investigations of FGF-2 – heparin complex interaction on the single-
molecule level as required for building the force landscape of this interaction. In tissues, the ECM 
is subject to physiological forces including shear stress of the interstitial fluid14 and at the same 
time to contraction forces exerted by surrounded cells.15 Fibroblastic cells undergo periodic, low 
force (~ 100 pN) subcellular contractions but with repetitive occurrence, which is increased at 
higher substrate stiffness or during differentiation.16-17  These findings suggest that tissue forces 
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and tissue deformations may be relevant for FGF-2’s ECM storage and release as well as for 
binding on cell surfaces. Apart from these physiological considerations, the interaction is also 
interesting in light of drug delivering matrices engineered from heparinized materials in tissue 
repair applications.18 Elucidating the underlying mechanism of the HS mediated interplay of GF 
with the ECM might provide new avenues for constructing advanced biomimetic scaffolds.  
Atomic force microscopy (AFM) has been successfully applied in various biomolecular 
measurements at single-molecule levels including receptor/ligand interactions and protein 
folding/unfolding experiments. We previously reported on a modular AFM design combining 
magnetic actuators for single-molecule force measurements.19  We integrated an electromagnet to 
a custom-built AFM head to enable direct magnetic actuation of cantilevers for better system 
dynamics. Furthermore, we employed this system to mechanically actuate functionalized 
micro/nano-particles against stationary cantilevers in a new mode of operation.20 Keeping the 
cantilever stationary and decreasing the size of the actuators drastically offered substantial 
advantages for stability, dynamics and resolution.   
In this study, we have performed biomolecular pulling as well as force clamp (single molecule 
constant force) AFM experiments using the method of microparticle-based magnetic actuators to 
probe the force landscape of heparin – FGF-2 interaction at the molecular level. We applied these 
methods to analyze unbinding forces and bond life-times between both interaction partners in a 
physiological state and at pathophysiological conditions, in which we mimicked a stressed cellular 
microenvironment by lowering the extracellular pH-value as result of hypoxia (low pO2 levels) as 
found in wound sites, inflammation, or cancer.21-22   
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Results  
Probability of specific heparin – FGF-2 interactions probed with a magnetically actuated 
atomic force microscope  
Heparin and FGF-2 interactions were studied on a molecular level using a customized AFM setup, 
combining a piezo actuator together with an electromagnetic manipulation system.19 Miniaturized 
magnetic, PEGylated (to reduce non-specific interactions) microparticles were used as secondary 
actuator for biomolecular force spectroscopy and force clamp experiments, as schematically 
represented in Figure 1B. We covalently immobilized low molecular weight heparin onto amine 
functionalized particles by NHS/EDC chemistry, whereas FGF-2 was physioadsorped onto the 
cantilever.  
At first, we aimed at analyzing the probability of specific unbinding events between both 
interaction partners in the described AFM system. The observed probability of bonding ruptures 
was 29.09 ± 3.11 % (Figure 2A). We optimized the concentration of the interacting molecules for 
probabilities of events at ~ 30 % to ensure that the majority of the recorded events are by virtue of 
single-molecular interactions.23  As controls the interaction between heparin decorated beads and 
FGF-2 was probed in the presence of a 10-fold excess of NaCl (impairing electrostatic interactions 
between both binding partners), and the probability of bonding was significantly reduced to 7.04 
± 4.2 %. Furthermore, saturation of the FGF-2 binding epitope with soluble heparin before the 
analysis resulted in a decrease to 1.96 ± 0.31 % of specific unbinding events, whereas non-specific 
interactions of FGF-2 with the unmodified magnetic particles were 1.53 ± 0.63 % of all events 
analyzed. Thus, the binding of the FGF-2 modified AFM cantilever and heparin decorated 
microparticles is specific and occurs via the heparin binding site of FGF-2.  
Unbinding of heparin – FGF-2 under constant loading rates 
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A representative force curve with 670 pN/s loading rate and with a 60 pN unbinding force to 
liberate FGF-2 from the FGF-2– heparin complex is presented in Figure 2B.  The data points 
labeled with black circles (Figure 2C) represents the most probable unbinding forces collected for 
low loading rates using our magnetic actuation method. Additional sets of biomolecular force 
measurements were repeated using the piezo actuation capability of our AFM system (red stars, 
Figure 2C) and a commercially available AFM system (blue triangles, Figure 2C). Single force 
spectroscopy histograms of all tested methods at increasing order of loading rates are displayed in 
Figures S1–S3. The unbinding forces for individual loading rates were distributed around a single 
force level as displayed in Figures S1–S3, supporting the observation of single-molecular events.  
All results using different methods and AFM systems were in a good agreement with each other 
as analyzed by linear regression (R2 values were 0.96 (low loading rate) and 0.91 (high loading 
rate), respectively) (Figure 2C). Notably, we were able to decipher the heparin – FGF-2 interaction 
on a single molecule level using the magnetic actuators in our customized AFM setup at the low 
force regime (101 – 104 pN/s) in contrast to the commercial AFM or by piezo actuation of the same 
customized AFM system (Figure 2C). The method of magnetic particle actuation offered the 
required level of stability and resolution to probe the molecular interactions at low force regime, 
which is relevant in physiological conditions and at cellular force levels. The corresponding Bell’s 
parameters (koff and Δx) for the heparin-FGF-2 complex at low (101 – 106 pN/s) and high (106 – 
107 pN/s) loading rates were calculated following the relationships (1) and (2) and are summarized 
in Table 1.  
The observation of continuous sequence of linear regimes suggested that there are two energy 
barriers along the reaction coordinate for the heparin-FGF-2 complex. The koff as determined for 
the low force regime was 0.62 s-1, whereas the koff value for the high loading rate regime was found 
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to be ~ 4500-fold higher (Table 1). The dissociation constant (koff) for the heparin – FGF-2 
interaction has been determined building off SPR analysis (koff = 0.43 ± 1.92*10
-2 s-1)13 and is in 
good agreement with our findings at the low force regime.  
The crystal structure of FGF-2 molecules indicates that the crystal lattice of a single molecule is 
approximately 3.5 nm x 3.5 nm x 3.5 nm (pdb file: 1BFB). The calculated value of Δx = 0.42 nm 
for the first force regime (Table 1) is within the geometry of a single FGF-2 molecule and within 
its binding interphase to heparin (Figure 1). The shorter value of Δx for the second force regime 
reflected the Bell’s parameters for higher pulling rates. 
All following biomolecular pulling and force clamp experiments were thus conducted with the 
customized magnetic actuator AFM setup. In conclusion, we have used two different AFM setups 
and three different actuation methods - including the magnetic actuator - during the pulling 
experiments at constant loading rates. The results were complementary and agreed well with each 
other, suggesting that the binding of a heparin functionalized magnetic bead or a heparin modified 
substrate to the cantilever resulted from the interaction between heparin and FGF-2.  
Life-time analysis of single heparin – FGF-2 interactions  
As next we elucidated the bond life-time spectrum of single heparin – FGF-2 interactions. Our 
magnetic bead actuation methodology (Figure 1B) was used for force clamp experiments as 
previously described.20  We deployed various clamping forces, ranging from 19.6 pN to 172.7 pN 
to study life-times between FGF-2 and heparin. A representative force clamp curve for 67 pN 
clamping force is shown in Figure 3A, resulting in an overall life-time of 400 ms of the FGF-2 
and heparin complex. We analyzed the life-time histograms for each clamping force. A 
representative life-time histogram together with the associated exponential density fit function for 
a clamping force of 39 pN with a mean value of the exponential fit function of 350 ms is shown in 
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Figure 3C. All other life-time histograms in respect to the deployed clamping forces are given in 
Figure S4. We also calculated the cumulative probabilities for the clamping forces as shown in 
Figure 3B for three selected clamping forces, respectively. The cumulative probabilities for each 
clamping force and the exponential cumulative probability density fit functions together with 95% 
confidence intervals are shown in Figure S5. Inverse life-times and corresponding clamping forces 
were exponentially plotted (Figure 3D), and correlated to the unbinding rate at that specific 
clamping force. The unbinding rate increased at elevated clamping forces, suggesting that the 
complex between heparin and FGF-2 is subject to simple slip bond dissociation. This observation 
is in agreement with the data presented in Figure 2C where the strength of the unbinding force 
increased with the molecular loading rate.  As a result of these force clamp measurements, koff and 
Δx values were calculated using equation (1) resulting in 2.44 s-1 and 0.02 nm, respectively.  
pH dependency of the  heparin – FGF-2 interaction 
Hypoxia in tissues acidifies the ECM down to pH 5 - 7.24 Providing that storage involves 
electrostatic interactions, local pH changes in the cellular microenvironment might contribute to 
alterations in GF release pattern. To investigate interactions between heparin and FGF-2 at three 
different pH-values (acidic: pH 5.5, physiological: pH 7.4, alkaline: pH 8.5) we first used 
conventional isothermal titration calorimetric measurements3 in order to record binding affinities 
as read out for FGF-2 stability and as prerequisite for further force spectroscopic experiments.    
Titration curves of low molecular heparin and FGF-2 are shown in Figure 4A-C.  Dissociation 
constants (KD), stochiometries (n) and changes in enthalpies (ΔH) were derived after non-linear 
fitting of the binding isotherms (Table 2). The binding of FGF-2 to heparin was enthalpically 
dominated and decreased linearly from -12.7  0.5 (kcal/mol) to -15.4  0.5 (kcal/mol), and to -
20.2  1.1 (kcal/mol) with elevating pH. The stochiometry remained constant at all tested pH-
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values with ~ three molecules of FGF-2 interacting with one molecule of heparin when FGF-2 was 
presented in excess. We were able to identify single KD values of ~ 200 nM for all tested pH values 
(Table 2). These are in good agreement with previous measurements using low molecular weight 
heparin (3000 Da) and FGF-2 in HEPES buffered saline at pH 7.4.3  Although the binding enthalpy 
(ΔH) of FGF-2 to heparin was reduced by approximately 18 % at acidic compared to physiological 
conditions, pH did not affect the equilibrium binding constant KD and, therefore, not the free 
enthalpy changes (ΔG) of binding between heparin and FGF-2. Notably, the entropic contributions 
(TΔS) of FGF-2 and heparin interaction decreased linearly from -3.8  0.46 (kcal/mol) to -11.4  
1.1 (kcal/mol) from acidic to alkaline conditions, respectively.  
We then switched to our magnetic actuated AFM-setup and performed biomolecular pulling 
measurements at the three different pH values as indicated above. We have collected force-curves 
between heparin and FGF-2 at different loading rates (50 pN/s – 7000 pN/s), at pH 5.5, pH 7.4, 
and pH 8.5, respectively. All collected force spectroscopy histograms are provided in the SI 
(Figures S3, S6, and S7). The most probable unbinding forces to break FGF-2 – interactions are 
depicted in Figure 4D and these increased linearly with respect to the logarithm of the applied 
loading rates.  In contrast to physiological and alkaline conditions, acidic pH increased then 
stability as demonstrated by increased unbinding forces to liberate FGF-2 from the binary complex 
(Figure 4D black triangles). Supporting this finding, the koff value of the heparin – FGF-2 complex 
was reduced by 23 % at acidic pH in comparison to physiological and alkaline conditions (Table 
3).  
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Discussion  
We detailed the interaction between FGF-2 and heparin at the single-molecular level using AFM-
based pulling and force clamp experiments, including assessments at different pH as relevant for 
(patho-)physiological conditions. Our customized AFM system, employing an electromagnet with 
magnetic beads as actuators, has been previously shown to enable force spectroscopic 
measurements between biotin and streptavidin serving as a well-studied high affinity model 
receptor ligand system at high loading rates (103 to 303 pN/s).20  Low affinity interactions – 
characteristic of the FGF-2 – heparin complex as reported here – required a stable AFM setup with 
maximum resolution particularly when used at the low loading rate regime (101 to 102 pN/s). Our 
setup enabled sensitive biomolecular force measurements as the cantilever is operated away from 
stationary surfaces, allowing low actuation speeds and decrease of contact forces acting on the 
interacting biomolecules. We were therefore able to vary the loading rate with more than five-
orders of magnitude (Figure 1C). Our applied magnetic bead actuation method was advantageous 
for the force clamp experiments, facilitating the stability of force levels applied to the FGF-2–
heparin complex, without the need of active feedback as needed in conventional AFM systems. 
We demonstrated that the interaction between FGF-2 and heparin was specific (Figure 2A) and 
had slip bond characteristics (as the life time decreased with the clamping force; Figure 3D). Life-
times of FGF-2–heparin complexes were short-lived with ~ 0.41 s without (as extrapolated) and ~ 
0.19 s in the presence of an tensile force (clamping force: 172 pN), suggesting that cells exerting 
forces in the pN-range on the ECM may modulate FGF-2 binding to the ECM. Through this 
mechanism the availability of bound pools for FGF-2 may indeed be controlled by surrounding 
cells with cells pulling at the ECM with increased forces as demonstrated during tissue 
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remodeling25 driving FGF-2 release – a paracrine growth factor (GF) being a potent regulator of 
cell growth and differentiation of primarily cells of mesodermal origin as required for tissue repair.  
Binding between FGF-2 and heparin is based on electrostatic (residues K135, Q134, N27, R120, 
K119, K129) interactions, hydrogen bonding and van der Waals forces26, resulting in strong 
enthalpic contributions during formation of the FGF-2–heparin complex. The determined barrier 
width Δx = 0.4 nm for the first force regime (Table 1) is about 11 %  along the axis of the FGF-2 
molecule, assuming the molecule fits in a cubic shape (3.5 nm x 3.5 nm x 3.5 nm).  
 Our results – as analyzed by ITC - revealed that acidic pH reduced intermolecular interactions 
(H), whereas the entropic contribution (TS) increased (Figure 4A–C; Table 2). For all 
conditions tested (acidic: pH 5.5, physiological: pH 7.4, alkaline: pH 8.5) the equilibrium 
dissociation constant KD and the overall free energy change (ΔG) remained constant. This 
reciprocal relationship between enthalpy and entropy, resulting in constant free energy levels of 
the interaction, is known as the enthalpy – entropy (H/S) compensation mechanism.27 We speculate 
that the release of hydrogen bonded and trapped water within the binding cavities of FGF-2 and 
heparin drove the entropy change at acidic conditions, an interaction, strongly impacted by pH. 
pH dependency of the FGF-2 – heparin interaction was further detailed by biomolecular pulling 
AFM experiments (Figure 4D). Recorded unbinding forces versus loading rates were 
indistinguishable at physiological and at basic pH-values. In contrast, acidic conditions resulted in 
a stabilized FGF-2– heparin complex as demonstrated by increased unbinding forces and an overall 
reduced koff value (Table 3). These insights are in line with previous studies, detailing transport of 
FGF-2 within the pericellular space which did not follow simple diffusion pattern.28 This is due to 
the fact that HS are ubiquitous present and in concentrations greatly exceeding FGFs levels in 
tissues. We speculate that binding of FGF-2 to HS is favored at acidic conditions to form locally 
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concentrated pools within the ECM (Figure 4E). These might contribute in gradient formation as 
needed to guide cells in angiogenesis or tissue development.29   
In summary, the insights provided here point to an intriguing self-regulating mechanism based on 
the observation that (i) acidic pH increases heparin binding of FGF-2 while (ii) strain releases 
FGF-2 from heparin. Pathophysiological pH decrease as of traumatic ischemia (reducing tissue pH 
and reflecting process (i) of our experiments) favors FGF-2 binding, thereby replenishment the 
diseased tissue with this trophic growth factor and directing it from the interstitial space to the sites 
in need. Once tissue repair has advanced to a state that repairing cells exert strain to the ECM 
(reflecting process (ii) of our experiments), bound FGF-2 is released, thereby regulating cell 
growth and differentiation. Certainly, future work is necessary to extrapolate the effects of pH 
dependency and nanomechanics – as observed on the molecular level here – to another hierarchical 
level including cells, tissues and, organs in health and disease.   
Conclusion 
 
In summary, these data provide first nanomechanical insights into the FGF-2 at the molecular level 
with a modular AFM system designed for biomolecular experiments.  Unbinding events between 
FGF-2 and heparin were specific with life-times decreasing with tensile force on the bond. Solution 
pH modulated FGF-2 – heparin binding as demonstrated by enhanced rupture forces at acidic 
conditions compared to physiological pH with implications for storage and release coordination in 
the extracellular space. AFM with magnetic bead actuation as demonstrated for protein-ligand 
interactions here is a convenient tool and may be of general relevance to study intramolecular 
forces and kinetics at the level of individual molecules.  
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Material & Methods 
 
Materials 
Carbenicillin disodium, phenylmethanesulfonyl fluoride (PMSF), poly(propylene glycol) 
(Average Mn ~ 2,000 Da), N-Hydroxysulfosuccinimide sodium salt (Sulfo-NHS), N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and 2-(N-Morpholino)ethane 
sulfonic acid hydrate (MES hydrate), bovine serum albumin (BSA) and phosphate buffered saline 
(PBS) tablets were purchased from Sigma Aldrich (Schnelldorf, Germany). Micromer®-M PEG-
NH2 beads (5 µm) were acquired from micromod Partikeltechnologie (Rostock, Germany). 
Enoxaparin sodium (low molecular weight heparin) was bought from Sanofi-Aventis (Clexane®, 
Frankfurt, Germany). Non-conductive Silicon Nitride MLCT-C type cantilever with nominal 
spring constant of 0.01 N/m–Veeco probes were from Bruker Cooperation (Karlsruhe, Germany). 
Silicon Nitride PNP-TR type cantilevers with nominal spring constant of 0.08 N/m were from 
Nanoworld (Neuchatel, Switzerland). All other chemicals used were at least of pharmaceutical 
grade and were purchased from Sigma-Aldrich (unless noted otherwise).  
Expression and purification of murine FGF-2 
Murine FGF-2 was subcloned and expressed as described before.30-31  Briefly, protein expression 
of the fusionprotein pHisTrx-FGF-2 was induced with 0.2 mM IPTG at OD600 = 0.6 and 
expression was performed at 30° C at 200 rpm. After 5h cells were harvested by centrifugation 
and were resuspended in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM PMSF, pH 7.5) and 
solubilized by sonification at 4° C. After centrifugation at 100,000 g for 1h at 4° C (L8-60M 
Ultracentrifuge, Beckman-Coulter, Brea, CA), the supernatant containing pHisTrx tagged FGF-2 
was purified by heparin-sepharose affinity chromatography using an FPLC system (Aekta Purifier, 
GE, Freiburg, Germany). After dialysis against PBS, supplemented with 1 mM DTT, the 
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fusionprotein pHisTrx-FGF-2 was cleaved by thrombin (GE, Freiburg, Germany) with a final 
concentration of 1U thrombin/mg fusionprotein at 4°C overnight. After stopping the reaction with 
1 mM PMSF, murine FGF-2 was purified by heparin affinity chromatography. Storage of murine 
FGF-2 was in PBS supplemented with 3 mM DTT as anti-oxidative agent at -80°C. FGF-2 
concentration was determined by UV-absorbance at λ= 280 nm, using an extinction coefficient of 
16766 ± 239 (E0.1% = 0.964) as described.32 
Decoration of magnetic beads with heparin via EDC/Sulfo-NHS coupling 
Magnetic and surface functionalized PEG-NH2 beads were used to reduce non-specific interactions 
and to prevent aggregation of the beads during the experiments. 1 mg Enoxaparin was added to 
the activation buffer (0.1 M MES, 0.5 M NaCl, pH 6.0) containing a tenfold molar excess of EDC 
and 30 mM Sulfo-NHS as described.30 The mixture was vortexed and incubated for 15 min at room 
temperature. After activation, the solution was transferred into concentrated phosphate buffer, 
containing 0.2 mg PEG-NH2 beads, to raise the pH above neutral. For at least 2 h the suspension 
was agitated with a Thermomixer comfort (Eppendorf, Hamburg, Germany) to maintain the 
particles dispersed in solution. After the coupling reaction the beads were washed several times 
using PBS with increased ionic strength (0.5 M NaCl) and Milli-Q water.  
 
Physioadsorption of FGF-2 onto cantilevers 
MLCT-C and PNP-TR cantilevers were incubated with a FGF-2 droplet with a final concentration 
of 112.5 µg/mL in PBS for 30 min at room temperature, prior to use. This concentration was 
chosen to observe probabilities of unbinding events of about 30 %. The spring constant values of 
all the cantilevers used during the experiments were calibrated using thermal noise method. 
Single molecule pulling experiments with magnetic bead actuation 
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Prior to injection of heparin decorated magnetic beads between the cantilever and a cover slip into 
the magnetic33 actuation based AFM system, the cover slip surface was blocked with 50 µL BSA  
with a final  concentration of 40 µg/mL for 30 minutes in order to avoid non-specific adhesions 
between the functionalized MLCT-C type FGF-2 cantilever and the cover glass. After washing 
away the excess BSA, 100 µL-droplet of PBS was placed into which the heparin-decorated beads 
were carefully injected using a micropipette. The concentration of heparin molecules immobilized 
onto the bead was adjusted for probabilities of unbinding events at about 30 %. Several hundreds 
of force curves were obtained at different loading rates, ranging from 101 to 104 pN/s by using the 
magnetic micro particles as actuators. Values of loading rates on individual force curves were 
recorded before the specific unbinding events and to avoid the additional effect of PEG-NH2 
polymer on the magnetic bead surface. Three different sets of control experiments were performed 
to test the specificity of the measured data. The first unbinding control experiment was performed 
in the presence of 10-fold excess of NaCl in the buffer. The second control experiment was 
performed after keeping the FGF-2 coated cantilevers inside the heparin solution overnight to 
saturate the FGF-2 molecules on the cantilever with heparin. In the last control experiment, binding 
of the FGF-2 coated cantilevers was tested against unmodified blank magnetic beads. Detailed 
information about the instrument setup and procedures of biomolecular pulling measurements by 
using the magnetic actuation method are described elsewhere.19,20  
Single molecule force clamp experiments with magnetic bead actuation 
In the force clamp experiments the custom build AFM system was used with electromagnetic 
actuation. The method of actuating magnetic particles against a stationary cantilever allows for the 
application of constant force on biomolecules to perform force clamp experiments without any 
active feedback.20 The magnetic field and gradient applied on the magnetic particle determine the 
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force, which can be kept constant by driving the electromagnet with a constant current signal. 
MLCT type cantilevers and the beads were prepared following the same procedures as described 
for force pulling experiments. The piezoactuator of the cantilever was used to grab magnetic beads 
and then constant force was applied on the beads until an unbinding event was observed. The 
duration of time between the instance when the force was applied and the instance of unbinding, 
i.e. life-time, was recorded for each condition. 
The Bell-Evans model was used for the calculation of the kinetic rate of dissociation (koff) and of 
the barrier width (Δx).34 (koff(F)) values were determined following the relationships: 
𝑘𝑜𝑓𝑓(𝐹) = 𝑘𝑜𝑓𝑓exp⁡(
𝐹
𝑘𝐵𝑇
Δ𝑥⁄
)                                                    (1) 
𝐹 =
𝑘𝐵𝑇
Δ𝑥
ln (
𝑟𝑓
𝑘𝐵𝑇
Δ𝑥⁄ ∙⁡𝑘𝑜𝑓𝑓
)                                                    (2) 
, where kB is the Boltzmann constant and T is the temperature.   
Single molecule pulling experiments with piezo actuation 
In addition to the method of magnetic bead actuation, single molecule pulling experiments were 
also performed using the conventional method of piezo actuation. Two sets of pulling experiments 
were performed using both the custom-built AFM setup and a commercially available AFM system 
(Dimension Edge, Bruker, Karlsruhe, Germany). PNP-TR type cantilevers were used for these 
experiments and the cantilevers were incubated in FGF-2 as described before. These cantilevers 
were tested against cover slips, which were incubated with heparin with a concentration of 20 
μg/mL at room temperature. Then, the excess heparin was washed away and the cover slips were 
later incubated for 30 minutes with 50 μL of BSA with a concentration of 40 µg/mL, which was 
washed away after incubation to avoid non-specific interactions. Finally, the experiments were 
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performed in a 100 μL-droplet of PBS. During the experiments, the piezo actuators of the AFM 
setups were actuated using triangular waves at various speeds to induce different loading rates 
ranging from 103 to 107 pN/s. 
 
Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) experiments were performed on a MicroCal–iTC 200 system 
(GE healthcare, Munich, Germany). 150 µM heparin dissolved in PBS supplemented with 0.5 mM 
DTT was titrated in 2 µL steps to 30 µM of FGF-2 in PBS containing 0.5 mM DTT in 4.0 s 
intervals at different pH values (5.5, 7.4, and 8.5). A constant temperature of 20° C and a stirring 
speed of 400 rpm were maintained throughout the experiment. A total number of 19 injections 
were performed. Heats determined in the absence of heparin were subtracted from the titration 
data before curve fitting. Additionally, an initial 0.4 µL injection was discarded from each dataset 
to remove the effect of titrant diffusion across the syringe tip during the equilibration process. 
After the integration of the injection peaks the area (heat exchange per injection) was plotted 
against the molar ratio of heparin/mFGF-2 assuming a sigmoidal fitting model using Origin® 
scientific plotting software to calculate the binding enthalpy ΔH and the dissociation constant KD. 
The free energy change (ΔG) was calculated from the relationship: 
  ΔG = RTln KD       (3) 
with R as the universal molar gas constant (1.99 cal *mol-1K-1) and T as the absolute temperature. 
The entropic term (TΔS) to the free energy was determined following the relationship: 
TΔS = ΔH  ̶  ΔG      (4) 
Statistics  
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Data were analyzed to perform one-way ANOVA using the software package MatLab 
(MathWorks,  Natick, Massachusetts, USA). Results were considered statistically significant at p 
≤ 0.05 (*) and results are displayed as mean with standard deviation (SD) unless specified 
otherwise.   
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Figure legends 
 
Figure 1: (A) Crystal structure of FGF-2 (grey) interacting with a heparin tetra fragment (blue 
colored by element). pdb file = 1BFB.  (B) Schematic representation of the dually actuated AFM 
setup, using piezo and/or magnetic actuation method. 
Figure 2: (A) Probability of unbinding force for heparin and FGF-2 single molecular interaction 
and control experiments using magnetic bead actuation method, collective data for the whole range 
of loading rates from 101 to 104 pN/s are used. (B) a sample force curve with 670 pN/s loading rate 
showing 60 pN unbinding force, for the corresponding event from the biomolecular interaction 
between the heparin labeled magnetic bead and FGF2 functionalized cantilever, (C) Unbinding 
force versus loading rates graph for heparin and FGF2 pulling experiments using magnetic bead 
actuation method (black circles), piezo actuation method on custom AFM setup (red stars), and on 
a commercial AFM system (Dimension Edge, Bruker) (blue triangulars). R2 values in linear 
regression for both energy barriers (low and high loading rates) were 0.96 and 0.91, respectively. 
Figure 3: (A) A representative force clamp curve with 67 pN clamping force showing 400 ms life-
time before unbinding. (B) Cumulative probability density graph of life-times under 19.6 pN 
(black), 38.9 pN (blue) and 61.6 pN (red) with their corresponding exponential fits. (C) Density 
histogram versus life time with exponential fitting. (D) Unbinding rate (life time-1) versus 
clamping force and linear fitting.  
Figure 4: Isothermal titration calorimetry curves between heparin and FGF-2 in PBS at a pH of 
(A) 5.5, (B) 7.4, and (C) 8.5, respectively. (D) The most probable unbinding force versus loading 
rates graph for heparin and FGF-2 interactions. Each labels represent s the experiments which are 
carried out in different pH environments i.e. pH 5.5 (black triangles), pH 7.4 (red circles) and pH 
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8.5 (blue triangles) using magnetic actuation method.  (E) Proposed pH dependency model for 
FGF-2 heparin interaction. 
 
Table: 1:  Bell’s parameters of heparin FGF-2 interaction at different loading rates regimes.  
Table: 2:  Thermodynamic parameters of heparin –FGF-2 interaction as analyzed by ITC.  
Table: 3:  Bell’s parameters of heparin FGF-2 interaction at different pH values. 
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Table 1: 
 Range of loading rate 
[pN] 
Barrier width, Δx  
[nm] 
Kinetic rate of dissociation, koff 
[s-1] 
Regime 1 101 – 106 0.4244 0.6198 
Regime 2 106 – 107 0.0231 2774 
 
Table 2: 
 T 
[K] 
# n KD 
[nM] 
H 
[kcal/mol] 
G 
[kcal/mol] 
TS 
[kcal/mol] 
pH 5.5 293.15 3 3.410.29 22120 -12.70.5 -8.90.05 -3.80.46 
pH 7.4 293.15 4 2.970.11 2325 -15.40.5 -8.90.01 -6.50.48 
pH 8.5 293.15 5 3.290.42 29332 -20.21.1 -8.80.07 -11.41.1 
 
Table 3: 
pH values Range of loading rate 
[pN] 
Barrier width, Δx  
[nm] 
Kinetic rate of dissociation, koff 
[s-1] 
pH 5.5 101 - 104 0.3293 0.5996 
pH 7.4 101 - 104 0.4191 0.7836 
pH 8.5 101 - 104 0.4407 0.7661 
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